Yahua Zhong

机构：Wuhan University, Zhongnan Hospital of Wuhan University · ORCID：0000-0003-2573-1080

发表论文 99 篇 · 总被引 1109 次 · h-index 21

代表论文

• Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial (2024 · Journal of Clinical Oncology · 被引 48)
• Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial (2025 · Cell Reports Medicine · 被引 29)
• PD-1/CD80+ small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression (2024 · Nature Communications · 被引 29)
• Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis (2024 · Scientific Reports · 被引 24)
• Abstract CT175: Safety, tolerability, pharmacokinetics, and antitumor activity of SHR-A1811 in HER2-expressing/mutated advanced solid tumors: A global phase 1, multi-center, first-in-human study (2023 · Cancer Research · 被引 13)
• Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma (2023 · Medicine · 被引 4)